Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Abiomed, Inc.    ABMD

ABIOMED, INC.

(ABMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
167.22(c) 169(c) 167.9(c) 168.08(c) 166.74(c) Last
625 251 626 605 618 058 697 107 458 196 Volume
+1.47% +1.06% -0.65% +0.11% -0.80% Change
More quotes
Financials (USD)
Sales 2020 849 M
EBIT 2020 251 M
Net income 2020 214 M
Finance 2020 490 M
Yield 2020 -
Sales 2021 944 M
EBIT 2021 278 M
Net income 2021 210 M
Finance 2021 742 M
Yield 2021 -
P/E ratio 2020 35,6x
P/E ratio 2021 35,7x
EV / Sales2020 8,27x
EV / Sales2021 7,17x
Capitalization 7 514 M
More Financials
Company
Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - product sales (96.4%): heart pumps (Impella brand); - service provision (3.6%): including... 
More about the company
Surperformance© ratings of Abiomed, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ABIOMED, INC.
02/06ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
02/06ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
02/06ABIOMED : Fiscal 3Q Earnings Snapshot
AQ
02/06ABIOMED : Announces Q3 FY 2020 Revenue of $222 Million and 31.7% Operating Margi..
BU
02/06ABIOMED, INC. : Slide show Q3 results
CO
02/06ABIOMED, INC. : SEC Filing 8K
CO
02/06ABIOMED, INC. : 3rd quarter results
CO
01/17ABIOMED, INC. : Report
CO
01/13Lululemon, At Home Group rise; Five Below, Abiomed fall
AQ
01/13ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
01/13ABIOMED : Announces Preliminary Q3 FY 2020 Revenue of $222 Million, up 10% Over ..
BU
2019ABIOMED, INC. : SEC Filing 10Q-3
CO
2019ABIOMED : to Present at the 38th Annual J.P. Morgan Healthcare Conference
BU
2019GRAPHIC : For veteran Netflix shareholders, it's been a very good decade
RE
2019ABIOMED : First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial Stu..
AQ
More news
News in other languages on ABIOMED, INC.
02/12WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
01/15WallStreet : 2 records sur 3 malgré doutes sur accord Phase-2
2019ABIOMED : Große randomisierte kontrollierte Studie soll zunehmende Epidemie der ..
2019ABIOMED : Un essai randomisé contrôlé majeur vise à endiguer l'épidémie croissan..
2019ABIOMED : Klinische Überprüfung bestätigt Kosteneffizienz von Impella bei Hochri..
More news
Analyst Recommendations on ABIOMED, INC.
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
02/20CEO Discusses Virus, Cash Flow -- WSJ
DJ
02/19Correction to GE Cash Drain Article
DJ
02/19GE Boss Warns of Quarterly Cash Drain From Boeing MAX -- Update
DJ
02/11Investor Activism Rises in Japan -- WSJ
DJ
02/06ILLUMINA : Former FDA Commissioner Scott Gottlieb Joins Illumina's Board
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ABIOMED, INC.
Duration : Period :
Abiomed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 204,83  $
Last Close Price 166,74  $
Spread / Highest target 43,9%
Spread / Average Target 22,8%
Spread / Lowest Target -10,6%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer & Senior Vice President
Todd A. Trapp CFO, Principal Accounting Officer & Vice President
Thorsten Sieß Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.-2.26%7 514
THERMO FISHER SCIENTIFIC3.10%134 308
DANAHER CORPORATION5.47%112 588
INTUITIVE SURGICAL, INC.3.71%71 107
BOSTON SCIENTIFIC CORPORATION-5.75%59 405
EDWARDS LIFESCIENCES CORPORATION0.27%48 232